About the Synthetic Biology Market Map
This market map tracks 110 startups across 8 categories in the Synthetic Biology landscape. DNA synthesis, biomanufacturing, lab automation, and computational biology programming biology like software. Curated by Hartmann Capital's venture research team, it provides a comprehensive view of the companies building in this space, from early-stage startups to growth-stage leaders.
Categories & Companies
DNA Synthesis & Gene Editing(16)
Twist Bioscience (Public, $903M) · Ginkgo Bioworks (Public, $2800M) · GenScript (Public, $595M) · Integrated DNA Technologies (Acquired) · Synthego (Series E, $497M) · Inscripta (Series E, $626M) · Mammoth Biosciences (Series D, $400M) · Ansa Biotechnologies (Series B, $122M) · Evonetix (Series B, $54M) · Ribbon Biolabs (Series A, $20M) · DNA Script (Series C, $225M) · Camena Bioscience (Series A, $10M) · Molecular Assemblies (Series B, $26M) · Constructive Bio (Series A, $73M) · Metagenomi (Public, $457M) · Atlas Data Storage (Seed, $155M)
Biomanufacturing & Fermentation(12)
Solugen (Series D, $600M) · LanzaTech (Public, $830M) · Genomatica (Series D, $440M) · Bolt Threads (Series E, $571M) · Resilience (Late Stage, $2000M) · Culture Biosciences (Series C, $107M) · Synonym (Series A, $30M) · DMC Biotechnologies (Series B, $34M) · Lygos (Series B, $68M) · Antheia (Series C, $152M) · Conagen (Series C, $60M) · Manus Bio (Series B, $47M)
Lab Automation & Robotics(13)
Opentrons (Series C, $261M) · Benchling (Series F, $412M) · Emerald Cloud Lab (Series C, $79M) · Arctoris (Series A, $23M) · Automata (Series C, $75M) · Lila Sciences (Series A, $550M) · Isomorphic Labs (Seed, $600M) · Lattice Automation (Seed, $5M) · TeselaGen (Series B, $17M) · Scispot (Seed, $6M) · Labstep (Series A, $8M) · Synthace (Series B, $42M) · Artificial (Series A, $28M)
Computational Biology & AI Design(13)
Generate Biomedicines (Series C, $700M) · Absci (Public, $425M) · Cradle (Series B, $103M) · EvolutionaryScale (Seed, $142M) · Profluent (Series B, $150M) · BigHat Biosciences (Series B, $100M) · Xaira Therapeutics (Series A, $1000M) · Evozyne (Series A, $81M) · Asimov (Series B, $200M) · Basecamp Research (Series A, $30M) · Bioptimus (Seed, $35M) · Noetik (Series A, $40M) · Deepcell (Series B, $63M)
Cell Engineering & Gene Therapy Tools(15)
Editas Medicine (Public, $741M) · Intellia Therapeutics (Public, $889M) · Beam Therapeutics (Public, $665M) · Prime Medicine (Public, $315M) · Caribou Biosciences (Public, $318M) · Verve Therapeutics (Acquired, $419M) · Scribe Therapeutics (Series B, $120M) · Arbor Biotechnologies (Series C, $134M) · Dyno Therapeutics (Series A, $100M) · Spotlight Therapeutics (Series A, $30M) · Precigen (Public, $450M) · Synlogic (Public, $326M) · Poseida Therapeutics (Acquired, $461M) · Umoja Biopharma (Series B, $210M) · Tierra Biosciences (Series A, $25M)
Enzyme Engineering & Protein Design(12)
Codexis (Public, $355M) · Novonesis (Public) · Arzeda (Series C, $65M) · Scindo (Seed, $5M) · Zymvol (Seed, $2M) · EvoEnzyme (Series A, $8M) · Pando Bioscience (Seed, $3M) · Colossal Biosciences (Series C, $435M) · BRAIN Biotech (Public) · Biomatter (Seed, $3M) · Baseimmune (Seed, $12M) · Enzymit (Seed, $5M)
Agricultural & Food Synbio(17)
Pivot Bio (Series D, $617M) · Indigo Agriculture (Series F, $1400M) · Inari Agriculture (Series E, $443M) · Pairwise (Series B, $190M) · Benson Hill (Public, $474M) · AgBiome (Series D, $226M) · Joyn Bio (Joint Venture, $100M) · Sound Agriculture (Series C, $105M) · Invaio Sciences (Series C, $142M) · Perfect Day (Series D, $750M) · The EVERY Company (Series C, $215M) · Geltor (Series B, $118M) · New Culture (Series A, $45M) · Helaina (Series B, $83M) · Remilk (Series B, $120M) · Formo (Series B, $101M) · Onego Bio (Series A, $40M)
Biosensors & Diagnostics(12)
Sherlock Biosciences (Series B, $115M) · Detect (Series B, $113M) · Viridos (Series C, $125M) · Sense Biodetection (Acquired) · Stemloop (Seed, $12M) · Tangen Biosciences (Series A, $6M) · Biomeme (Series B, $30M) · Cardea Bio (Acquired, $21M) · Genalyte (Series C, $98M) · GnuBIO (Acquired) · Miroculus (Series B, $32M) · Volta Labs (Series A, $21M)
Frequently Asked Questions
- What is the Synthetic Biology market map?
- The Synthetic Biology market map is a curated overview of 110 startups across 8 categories : DNA Synthesis & Gene Editing, Biomanufacturing & Fermentation, Lab Automation & Robotics, Computational Biology & AI Design, Cell Engineering & Gene Therapy Tools, Enzyme Engineering & Protein Design, Agricultural & Food Synbio, Biosensors & Diagnostics. DNA synthesis, biomanufacturing, lab automation, and computational biology programming biology like software. It is maintained by Hartmann Capital's venture research team.
- How many startups are tracked?
- This map currently tracks 110 startups across 8 categories: DNA Synthesis & Gene Editing (16 companies), Biomanufacturing & Fermentation (12 companies), Lab Automation & Robotics (13 companies), Computational Biology & AI Design (13 companies), Cell Engineering & Gene Therapy Tools (15 companies), Enzyme Engineering & Protein Design (12 companies), Agricultural & Food Synbio (17 companies), Biosensors & Diagnostics (12 companies).
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.
- How often is this map updated?
- The Synthetic Biology market map is updated on a rolling basis as new startups emerge, companies raise funding rounds, or the competitive landscape shifts.